KW-0761 or Investigator’s Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Condition(s):Adult T-cell Leukemia-LymphomaLast Updated:September 19, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Adult T-cell Leukemia-LymphomaLast Updated:September 19, 2018Completed
Condition(s):Adult T-Cell Leukemia-LymphomaLast Updated:May 29, 2018Completed
Condition(s):Cutaneous T-Cell Lymphoma; Leukemia-Lymphoma, Adult T-CellLast Updated:November 27, 2012Terminated
Condition(s):Adult T-cell Leukemia-lymphomaLast Updated:March 29, 2017Completed
Condition(s):Adult T-Cell Leukemia (ATL)Last Updated:November 14, 2023Completed
Condition(s):Adult T-cell Leukemia/LymphomaLast Updated:February 16, 2024Active, not recruiting
Condition(s):Adult T Cell Leukemia; Adult T Cell LymphomaLast Updated:June 9, 2023Terminated
Condition(s):Adult T-cell Leukemia-Lymphoma; ATLLLast Updated:January 2, 2024Recruiting
Condition(s):Adult T-Cell Lymphoma (ATL)Last Updated:October 5, 2020Completed
Condition(s):Adult T Cell Leukemia/LymphomaLast Updated:May 23, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.